We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » LINCARE TO PAY $10 MILLION IN DAMAGES FOR ILLEGAL KICKBACKS

LINCARE TO PAY $10 MILLION IN DAMAGES FOR ILLEGAL KICKBACKS

May 25, 2006

HHS' Office of Inspector General (OIG) has entered into a settlement agreement and corporate integrity agreement (CIA) with Lincare Holdings and its subsidiary Lincare, the agency announced May 15.

Lincare, headquartered in Clearwater, Fla., is one of the largest durable medical equipment suppliers in the U.S. The settlement resolves allegations that Lincare paid illegal kickbacks and violated the Physician Self-Referral, or Stark, Law, the OIG said. Under the settlement -- the largest civil monetary penalty ever collected by OIG -- the company paid $10 million and entered into a five-year company-wide CIA.

Lincare engaged in a nationwide scheme to pay physicians illegal kickbacks to refer patients to the company, the OIG alleged. The company rewarded referring physicians with sporting and entertainment tickets, gift certificates, golf outings and equipment, fishing trips, meals, advertising expenses, and office and medical equipment, the OIG said. The kickbacks were disguised as consulting fees.

The OIG statement can be viewed at http://www.oig.hhs.gov/publications/docs/press/2006/Lincare051506.pdf (http://www.oig.hhs.gov/publications/docs/press/2006/Lincare051506.pdf).

()a href="http://www.fdanews.com/ddl/33_21/" target=_blank>

KEYWORDS FDAnews Device Daily Bulletin

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

  • Effective text

    Pfizer/BioNTech Vaccine Equally Effective for All Age Groups, Israeli Study Says

  • Siemens Healthineers logo

    Siemens Healthineers’ COVID-19 Antigen Lab Test Receives CE Mark

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing